Exosens (CHIX:EXENSP) Accounts Receivable: €73.1 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:EXENSP Exosens SA CHIX:EXENSP
45 GF Score
Price €63.70
! 7 Warning Signs
View Full Analysis

What is Exosens Accounts Receivable?

Exosens CHIX:EXENSP 45 Accounts Receivable is €73.1 Mil as of Dec. 2025. GuruFocus rates CHIX:EXENSP with a GF Score™ of 45/100. The stock has 7 warning signs investors should review.

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Exosens's accounts receivables for the quarter that ended in Dec. 2025 was €73.1 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Exosens's Days Sales Outstanding for the quarter that ended in Dec. 2025 was 83.96.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Exosens's Net-Net Working Capital per share for the quarter that ended in Dec. 2025 was €-4.42.


Exosens Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Exosens's Days Sales Outstanding for the quarter that ended in Dec. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=73.1/158.885*91
=83.96

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Exosens's accounts receivable are only considered to be worth 75% of book value:

Exosens's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2025 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(101.9+0.75 * 73.1+0.5 * 105.1-433.3
-0-0)/50.689
=-4.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Exosens Accounts Receivable Related Terms


Exosens Accounts Receivable Historical Data

* Premium members only.

The historical data trend for Exosens's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Exosens Accounts Receivable Chart

Exosens Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Receivable
Get a 7-Day Free Trial 35.58 32.68 69.19 70.98 73.10

Exosens Semi-Annual Data
Dec20 Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Receivable Get a 7-Day Free Trial Premium Member Only 69.19 60.31 70.98 83.88 73.10
CHIX:EXENSP
45GF Score
Exosens SA CHIX:EXENSP
Accounts Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Exosens Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Frequently Asked Questions Learn more about Accounts Receivable →
What does a Accounts Receivable of €73.1 Mil mean?
Exosens (CHIX:EXENSP) has a Accounts Receivable of €73.1 Mil as of Dec. 2025. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Exosens and its competitors.
Is Exosens' Accounts Receivable too high?
Exosens' current Accounts Receivable is €73.1 Mil. Overall, Exosens has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Exosens' Accounts Receivable compare to VRT and BE?
Exosens' Accounts Receivable of €73.1 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for an Industrial Products company?
A good Accounts Receivable depends on the Industrial Products industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Exosens and its competitors. Exosens's current Accounts Receivable is €73.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Exosens stock overvalued right now?
Exosens (CHIX:EXENSP) has a current Accounts Receivable of €73.1 Mil. The current Accounts Receivable is €73.1 Mil. Exosens' overall GF Score™ is 45/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Exosens (CHIX:EXENSP), the current Accounts Receivable is €73.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Exosens Business Description

Address 18 Avenue de Pythagore, Domaine de Pelus, Axis Business Park Bat 5E, Merignac, FRA, 33700
Exosens SA is a high-tech company specializing in electro-optical technologies for amplification, detection, and imaging. It offers products such as night vision tubes, ultraviolet cameras, travelling wave tubes, and various detectors for defense, life sciences, nuclear, and industrial sectors. With multiple production sites in Europe and North America. The company's activities are organized into two main segments: Amplification, which focuses on electron or electromagnetic wave amplification systems mainly used in defense night vision equipment and generates the majority of its revenue, and Detection & Imaging, which provides high value-added components for commercial markets such as nuclear power, research, and industrial applications.
45GF Score

Get the complete analysis for CHIX:EXENSP

Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€63.70
Price